This strategy demonstrated that inhibiting PKCα in the first step makes it possible to condition the MCF-7 cells into a low tumor profile due to the inhibition of critical cancer pathways (Figure 3 and Figure 4). This evidence concerns the gene PRKCA and neoplasm.